All news

Are Investors Undervaluing Baxter International (BAX) Right Now?

Alpha Vantage · Yahoo Finance · · AI-summarised by FinFlash

Zacks Equity Research suggests that Baxter International (BAX) and Zimmer Biomet (ZBH) appear to be undervalued based on various financial metrics. Both companies currently hold a Zacks Rank #2 (Buy) and an "A" grade for Value, with BAX showing attractive P/E, PEG, P/B, and P/S ratios compared to its industry averages. The article highlights these metrics as indicators for value investors to consider.

Read original source

BAX company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.